SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 36 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Holders of 5% or more of SOPH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of SOPHiA GENETICS SA, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Akre Capital Management LLCSuperinvestorAkre Capital Management | 13G | 5.60%3.72M shares | New | Jun 27, 20251 filing | Jun 27, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on SOPHiA GENETICS SA, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 27, 20255:47 PM ET | Akre Capital Management LLCand 2 othersSuperinvestorAkre Capital Management | 13G | 5.60%3.72M shares | New | Jun 20, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell SOPHiA GENETICS SA shares.
No Form 144 notices for SOPHiA GENETICS SA are on file.